15-90090492-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_002168.4(IDH2):c.360G>A(p.Glu120Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,613,690 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 1 hom. )
Consequence
IDH2
NM_002168.4 synonymous
NM_002168.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0730
Publications
2 publications found
Genes affected
IDH2 (HGNC:5383): (isocitrate dehydrogenase (NADP(+)) 2) Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. This protein may tightly associate or interact with the pyruvate dehydrogenase complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
IDH2 Gene-Disease associations (from GenCC):
- mitochondrial diseaseInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- d-2-hydroxyglutaric aciduria 2Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- D-2-hydroxyglutaric aciduriaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 15-90090492-C-T is Benign according to our data. Variant chr15-90090492-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 435489.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.073 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000119 (174/1461386) while in subpopulation MID AF = 0.00299 (16/5354). AF 95% confidence interval is 0.00187. There are 1 homozygotes in GnomAdExome4. There are 88 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 19 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IDH2 | NM_002168.4 | c.360G>A | p.Glu120Glu | synonymous_variant | Exon 3 of 11 | ENST00000330062.8 | NP_002159.2 | |
| IDH2 | NM_001289910.1 | c.204G>A | p.Glu68Glu | synonymous_variant | Exon 3 of 11 | NP_001276839.1 | ||
| IDH2 | NM_001290114.2 | c.-17-1745G>A | intron_variant | Intron 1 of 8 | NP_001277043.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IDH2 | ENST00000330062.8 | c.360G>A | p.Glu120Glu | synonymous_variant | Exon 3 of 11 | 1 | NM_002168.4 | ENSP00000331897.4 | ||
| IDH2 | ENST00000540499.2 | c.204G>A | p.Glu68Glu | synonymous_variant | Exon 3 of 11 | 2 | ENSP00000446147.2 | |||
| IDH2 | ENST00000559482.5 | c.207+1061G>A | intron_variant | Intron 2 of 7 | 5 | ENSP00000453016.1 | ||||
| IDH2 | ENST00000560061.1 | n.116-1745G>A | intron_variant | Intron 1 of 8 | 2 | ENSP00000453254.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152186Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
19
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000127 AC: 32AN: 251190 AF XY: 0.000155 show subpopulations
GnomAD2 exomes
AF:
AC:
32
AN:
251190
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000119 AC: 174AN: 1461386Hom.: 1 Cov.: 32 AF XY: 0.000121 AC XY: 88AN XY: 726994 show subpopulations
GnomAD4 exome
AF:
AC:
174
AN:
1461386
Hom.:
Cov.:
32
AF XY:
AC XY:
88
AN XY:
726994
show subpopulations
African (AFR)
AF:
AC:
1
AN:
33472
American (AMR)
AF:
AC:
16
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
10
AN:
26136
East Asian (EAS)
AF:
AC:
0
AN:
39700
South Asian (SAS)
AF:
AC:
12
AN:
86224
European-Finnish (FIN)
AF:
AC:
1
AN:
53418
Middle Eastern (MID)
AF:
AC:
16
AN:
5354
European-Non Finnish (NFE)
AF:
AC:
111
AN:
1112004
Other (OTH)
AF:
AC:
7
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000125 AC: 19AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74468 show subpopulations
GnomAD4 genome
AF:
AC:
19
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
74468
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41560
American (AMR)
AF:
AC:
2
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5192
South Asian (SAS)
AF:
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12
AN:
68022
Other (OTH)
AF:
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Feb 14, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
D-2-hydroxyglutaric aciduria 2 Benign:1
Apr 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.